Skip to main content
Premium Trial:

Request an Annual Quote

GeneWiz Receives CLIA Certification

NEW YORK (GenomeWeb News) – DNA testing contract research organization GeneWiz today said that it has obtained Clinical Laboratory Improvement Amendments licensure and certificate of registration from New Jersey, allowing it to offer clinical genomic testing.

In addition to KRAS and EGFR tests, the company plans to continue developing CLIA-certified assays based on traditional platforms as well as new technologies, such as next-generation sequencing, it said.

GeneWiz added that it recently expanded its laboratory operations at its South Plainfield, NJ, headquarters to include a clean suite dedicated to processing clinical and preclinical samples. The laboratory will allow the company to expand its services into biologic drug and cell bank characterization testing, clinical trial investigations, and clinical diagnostic testing.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.